MIAMI LAKES, Fla., Jan. 5, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) Chief Executive Officer, Mohan Gopalkrishnan, will present a business overview and update at the OneMedForum investor conference on Monday, January 12th, 2015 at 2:40 pm PST (5:40 pm EST).
A live webcast and replay of the presentation will be available on the investor relations section of the Company's corporate website, www.erbadiagnostics.com. The replay of the webcast will be archived for 90 days.
OneMedForum's objective is to assemble the most promising companies and technologies in health and medicine to connect with investors and executives. The 8th Annual OneMedForum will be held at the San Francisco Marriott Marquis, January 12-13th 2015. To learn more about the conference, presenting companies, or investor registration, visit www.onemedconferences.com.
About ERBA Diagnostics, Inc.
ERBA Diagnostics, Inc. (NYSE MKT:ERB) is a fully integrated in vitro diagnostics company, offering a comprehensive suite of clinical testing products throughout the U.S. and emerging markets. The Company serves as a one-stop shop for the testing needs of the growing number of smaller hospitals, reference labs, and physician clinics. ERBA Diagnostic's line of proprietary and automated instruments, test kits, and reagents provide customers with autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. www.erbadiagnostics.com
CONTACT: Investors & Media Tom Baker Stonegate, Inc. Tel: 617.532.0624 firstname.lastname@example.org
Source:ERBA Diagnostics Inc